Scholarly Index
Sergey Shcherbinin
Eli Lilly (United States); 8,302 total citations; 183 total publications; best world rank #267
Eli Lilly (United States)
8,302Total citations
183Total publications
29H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Alzheimer's disease research and treatments | 2021-2025 | 308 | US 126 | 96.67 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 519 | US 219 | 95.66 |
| Cholinesterase and Neurodegenerative Diseases | 2021-2025 | 267 | US 26 | 86.61 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 610 | US 201 | 82.25 |